Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Med.

Sec. Infectious Diseases: Pathogenesis and Therapy

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1603102

This article is part of the Research TopicHTLV-1 and EBV-related disorders: pathogenesis and clinical advancesView all 8 articles

A Review of Cutaneous Manifestations of HTLV-Associated Adult T-cell Leukemia/Lymphoma

Provisionally accepted
  • 1New York Presbyterian Hospital, New York, United States
  • 2Columbia University Irving Medical Center, Columbia University, New York, New York, United States

The final, formatted version of the article will be published soon.

Adult T-cell leukemia/lymphoma (ATLL) is a rare aggressive mature T-cell neoplasm caused by the human T-cell leukemia virus type 1 (HTLV-1). The disease predominantly affects patients from endemic regions of Japan, the Caribbean, Sub-Saharan Africa, and South America. Cutaneous involvement of ATLL is common and may appear before or in the absence of systemic involvement. However, the lesions are non-specific and often mimic more common inflammatory and neoplastic skin diseases, making diagnosis challenging. Moreover, morphology is variable among patients, ranging from macules and papules to tumors and erythroderma. Recent data suggests that the presence of cutaneous lesions and lesion morphology are important for prognostication and for guiding treatment. Here, we provide an overview of the spectrum of cutaneous findings in ATLL, highlighting their diagnostic, prognostic, and therapeutic implications. We emphasize the importance of early recognition and workup of suspicious skin lesions, particularly in endemic regions or high-risk populations. Finally, we describe fundamental concepts and controversies and highlight current knowledge gaps.

Keywords: ATLL, HTLV 1, HTLV, Leukemia, Lymphoma

Received: 31 Mar 2025; Accepted: 27 Aug 2025.

Copyright: © 2025 LeWitt and Gru. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Alejandro A. Gru, Columbia University Irving Medical Center, Columbia University, New York, NY 10027, New York, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.